Randomized controlled trial of the effects of high intensity and low-to-moderate intensity exercise on physical fitness and fatigue in cancer survivors: results of the Resistance and Endurance exercise After ChemoTherapy (REACT) study
BMC Medicine 2015, 13:275 (29 October 2015)
In a randomized controlled trial, high and low-to-moderate intensity exercise comprising resistance and endurance training is safe and reduces fatigue in cancer survivors, suggesting that exercise should be recommended to patients following cancer treatment.
Effects of an 18-week exercise programme started early during breast cancer treatment: a randomised controlled trial
van den Buijs,
ten Bokkel Huinink,
van der Wall,
BMC Medicine 2015, 13:121 (8 June 2015)
This article is part of a collection on
Spotlight on breast cancer...
In a randomized controlled trial, an exercise intervention reduces treatment-associated fatigue and improves fitness in women with breast cancer over an 18 week period, highlighting the benefits of physical activity during cancer treatment.
Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses
BMC Medicine 2015, 13:28 (6 February 2015)
Michael Berk and colleagues review the common immunological factors associated with fatigue across different diseases including neuroinflammation, and propose that peripheral immune activation should be considered in patients with idiopathic fatigue.
Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics
BMC Medicine 2013, 11:205 (17 September 2013)
As multiple sclerosis (MS) and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) share many symptoms and neuro-immune characteristics, Gerwyn Morris and Michael Maes suggest that CFS should be considered as a neuro-immune disease and that MS patients may be susceptible to develop CFS symptoms.